Clinical Trial Update: ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.

View source ↗

Summary

This clinical trial update discusses pemetrexed (ALIMTA) alone or in combination with cisplatin for malignant mesothelioma and notes marketing approval for the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma

Drugs mentioned

• Alimta (pemetrexed)
• CISPLATIN (cisplatin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Mesothelioma | Status: APPROVED_FOR_MARKETING